Anti-chondroitin-sulfate-E antibody

US9745386B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9745386-B2
Application numberUS-201515128913-A
CountryUS
Kind codeB2
Filing dateMar 31, 2015
Priority dateMar 31, 2014
Publication dateAug 29, 2017
Grant dateAug 29, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides an antibody that can react with chondroitin sulfate E at a high specificity and that can be used for, for example, the detection, isolation, and so forth, of specific sulfated polysaccharides. The present invention relates to a novel anti-chondroitin sulfate E antibody that reacts with chondroitin sulfate E and does not react with chondroitin sulfate A, does not react with chondroitin sulfate B, and does not react with chondroitin sulfate D.

First claim

Opening claim text (preview).

What is claimed is: 1. A monoclonal antibody produced by a hybridoma having International Accession number NITE BP-01808 or NITE BP-01809 wherein the antibody specifically binds chondroitin sulfate E. 2. The antibody according to claim 1 that does not specifically bind with chondroitin sulfate A, does not specifically bind with chondroitin sulfate B, and does not specifically bind with chondroitin sulfate D. 3. The antibody according to claim 2 , which also does not specifically bind with any of chondroitin sulfate C, fully desulfated chondroitin sulfate C, heparin, heparan sulfate, heparosan, keratan sulfate, hyaluronic acid, and 6-O-desulfated chondroitin sulfate E. 4. The antibody according to claim 1 , which is obtained by carrying out an immunization using as antigen a substance in which a lipid is linked to chondroitin sulfate E. 5. The antibody according to claim 4 , wherein the lipid is dipalmitoyl-L-(α-phosphatidyl)ethanolamine. 6. A hybridoma having International Accession number selected from the group consisting of NITE BP-01808 and NITE BP-01809. 7. A method of detecting chondroitin sulfate E present in a sample, comprising performing an immunoassay comprising contacting the antibody of claim 1 with the sample to form a complex with chondroitin sulfate E present in the sample; and detecting the complex, wherein the presence of the complex indicates the presence of chondroitin sulfate E in the sample. 8. A detection kit for chondroitin sulfate E, comprising at least the antibody according to claim 1 .

Assignees

Inventors

Classifications

  • Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides · CPC title

  • C07K16/44Primary

    against material not provided for elsewhere {, e.g. haptens, metals, DNA, RNA, amino acids} · CPC title

  • Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value · CPC title

  • Specific host cells or culture conditions, e.g. components, pH or temperature · CPC title

  • for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9745386B2 cover?
The present invention provides an antibody that can react with chondroitin sulfate E at a high specificity and that can be used for, for example, the detection, isolation, and so forth, of specific sulfated polysaccharides. The present invention relates to a novel anti-chondroitin sulfate E antibody that reacts with chondroitin sulfate E and does not react with chondroitin sulfate A, does not r…
Who is the assignee on this patent?
Seikagaku Kogyo Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07K16/44. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).